A member of the Vectura Group of companies
Company Profile
About Us
Mission, Culture & Values
Leadership team
Partnership
Quality Charter
HSE Commitment
Location
Our Value Proposal
Development Plant
New Product Introduction Department
Early Stage Program
Scale-up Program
Technology Transfer
Production Plant
Technical capabilities
Bulk Manufacturing
Packaging
Support Services
Supply Chain
Quality
Our Technologies
Oral Drug Delivery Technologies
Geomatrix®
Geoclock®
Soctec®
Bioavaibility Enhancers
Medicated chewing-gum
News & Events
News & Events
Publications
Careers
Working at Skyepharma
Current vacancies
Application Form
Contact Us
A member of the Vectura Group of companies
Company Profile
About Us
Mission, Culture & Values
Leadership team
Partnership
Quality Charter
HSE Commitment
Location
Our Value Proposal
Development Plant
New Product Introduction Department
Early Stage Program
Scale-up Program
Technology Transfer
Production Plant
Technical capabilities
Bulk Manufacturing
Packaging
Support Services
Supply Chain
Quality
Our Technologies
Oral Drug Delivery Technologies
Geomatrix®
Geoclock®
Soctec®
Bioavaibility Enhancers
Medicated chewing-gum
News & Events
News & Events
Publications
Careers
Working at Skyepharma
Current vacancies
Application Form
Contact Us
ONE-STOP-SHOP
Skyepharma is designed as a One-Stop-Shop committed to maximizing value creation across all pharmaceutical lifecycle stages
Learn more
CENTER OF EXCELLENCE
Skyepharma provides a full range of integrated services through State-of-the-Art infrastructure and accomplished experts
Learn more
Skyepharma is the solution provider for development and manufacturing of high quality and complex oral solid dosage forms
SOLUTION PROVIDER
Learn more
WHO ARE WE - OUR KEY DIFFERENTIATORS
Learn more
STATE OF THE ART cGMP FACILITY
Learn more
solution provider
Learn more
Skyepharma invests in state-of-the-art equipment in laboratories capabilities
12 avril 2018 – Skyepharma’s Analytical Development department recently acquired a BET Analyzer, used for Surface area and Pore...
Read More
SKYEPHARMA improves time to market
28 février 2018 – David LESCUYER – EVP Oral Business, Vectura Group of Companies – President...
Read More
SKYEPHARMA ACQUIRES A NEW MARCHESINI BOTTLING LINE
7 février 2018 – 4.1 million Investment results in upgrade to SKYEPHARMA Development & Manufacturing site...
Read More
LOOKING FOR A CDMO PARTNER ?
Our unique selling point is to be a solution provider ensuring customer satisfaction.
CONTACT US
